Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer

被引：0
|
作者：
Yong Du
Ignasi Carrio
Giuseppe De Vincentis
Stefano Fanti
Harun Ilhan
Caroline Mommsen
Egbert Nitzsche
Francis Sundram
Wouter Vogel
Wim Oyen
Val Lewington
机构：
[1] The Royal Marsden NHS Foundation Trust,Department of Nuclear Medicine & PET/CT
[2] Hospital Sant Pau,undefined
[3] Policlinico Umberto I University Hospital Rome,undefined
[4] University Hospital Bologna,undefined
[5] Ludwig-Maximilians-University Hospital,undefined
[6] Praxis für diagnostische und therapeutische Nuklearmedizin Berlin,undefined
[7] Canton Hospital Aarau,undefined
[8] University Hospital Southampton NHS Foundation Trust,undefined
[9] The Netherlands Cancer Institute,undefined
[10] The Institute of Cancer Research,undefined
[11] Guy’s and St Thomas’ NHS Foundation Trust,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Bone metastases; Castration-resistant prostate cancer; Nuclear medicine; Radium dichloride; Ra-223; Targeted alpha therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1671 / 1678
页数：7
相关论文
共 50 条
  • [21] Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer - role of radium-223
    Mukherji, Deborah
    El Dika, Imane
    Temraz, Sally
    Haidar, Mohammed
    Shamseddine, Ali
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 373 - 380
  • [22] Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer
    Saganich, Christopher
    Zgaljardic, Michael
    [J]. HEALTH PHYSICS, 2022, 122 (03): : 433 - 439
  • [23] Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223
    Odo, Ugochukwu
    Vasudevamurthy, Ashwin K.
    Sartor, Oliver
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E501 - E502
  • [24] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Marie Øbro Fosbøl
    Peter Meidahl Petersen
    Gedske Daugaard
    Søren Holm
    Andreas Kjaer
    Jann Mortensen
    [J]. Annals of Nuclear Medicine, 2018, 32 : 16 - 21
  • [25] Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer
    Wong, William W.
    Anderson, Eric M.
    Mohammadi, Homan
    Daniels, Thomas B.
    Schild, Steve E.
    Keole, Sameer R.
    Choo, C. Richard
    Tzou, Katherine S.
    Bryce, Alan H.
    Ho, Thai H.
    Quevedo, Fernando J.
    Vora, Sujay A.
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E969 - E975
  • [26] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, Marie Obro
    Petersen, Peter Meidahl
    Daugaard, Gedske
    Holm, Soren
    Kjaer, Andreas
    Mortensen, Jann
    [J]. ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 16 - 21
  • [27] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Nilsson, Sten
    [J]. CURRENT ONCOLOGY REPORTS, 2016, 18 (02) : 1 - 12
  • [28] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [29] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Sten Nilsson
    [J]. Current Oncology Reports, 2016, 18
  • [30] Radium-223 Chloride A New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma
    Pinto, Alvaro
    Cruz, Patricia
    [J]. DRUGS IN R&D, 2012, 12 (04) : 227 - 233
12345